Tumor Embolization Devices Market Forecast 2025-2034: Growth Dynamics, Emerging Trends, and Strategic Opportunities
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers Contributing to the Growth and Expansion of the Tumor Embolization Devices Market?
The increasing prevalence of cancer is also expected to boost the tumor embolization devices market. For example, Macmillan Cancer Support projected that by 2025, 3.5 million people in the UK would have cancer, with the number rising to 4 million by 2030. This increasing incidence of cancer is expected to drive the demand for tumor embolization devices.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3352&type=smp
How Has the Tumor Embolization Devices Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?
The tumor embolization devices market size has grown strongly in recent years. It will grow from $1493.6 billion in 2024 to $1600.57 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. This growth is attributed to the increasing number of minimally invasive procedures, technological advancements, and the rising incidence of cancer, particularly in the aging population.
The tumor embolization devices market is expected to see substantial growth, reaching $2286.1 billion by 2029 at a CAGR of 9.3%. This growth is driven by the rising adoption of personalized medicine, combination therapies, image-guided embolization, and telemedicine. Major trends include innovations in embolic agents, transarterial chemoembolization (TACE), the use of embolization in palliative care, and the development of image-guided procedures.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3352
What Are the Key Market Innovations in theTumor Embolization Devices Market Over the Coming Years?
In the tumor embolization devices market, innovations such as enhanced angiography systems are improving the accuracy and effectiveness of tumor-targeted treatments. Siemens Healthineers, a German healthcare company, launched the Artis Icono Ceiling angiography system in June 2022. This ceiling-mounted system offers rapid 3D data acquisition, improving precision in tumor embolization procedures and minimizing motion artifacts.
Who Are the Leading Market Players Fueling Growth in the Tumor Embolization Devices Market Trend?
Major companies operating in the tumor embolization devices market include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc., Cook Medical LLC, AngioDynamics Inc., Siemens Healthineers AG, Johnson & Johnson, Penumbra Inc., Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., Kaneka Corporation, Imagion Biosystems Ltd., Guerbet, BTI Biotechnology Institute S.L., BTG International, Avinger Inc., Shape Memory Medical Inc., Delcath Systems Inc., Endoshape Inc., InSitu Technologies Inc., Monteris Medical Corporation, NeuWave Medical Inc., Neoprobe Corporation, OncoSec Medical Incorporated, Helomics Corporation, Hologic, Surefire Medical Inc., Varian Medical Systems Inc.
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
How is the Global Tumor Embolization Devices Market Segemented?
The tumor embolization devices market covered in this report is segmented –
1) By Type: Radioembolic Agents, Non-radioactive Embolic Agents
2) By Application: Cancer Tumors, Noncancerous Tumors
3) By End User: Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers
Subsegments:
1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres, Holmium-166 Microspheres
2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs), Microspheres (Polyvinyl Alcohol – PVA Particles), Gelatin Sponges, Liquid Embolic Agents (Onyx, Glue-Based Agents)
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=3352&type=smp
Which Geographics are Influencing the Growth of the Tumor Embolization Devices Market?
North America was the largest region in the tumor embolization devices market in 2023. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Global Tumor Embolization Devices Market 2025, By The Business Research Company:
Pain Management Devices And Therapies Global Market Report 2024
Implantable Drug Delivery Devices Global Market Report 2024
Cardiac Assist Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
